5 years of historical data (2020–2024) · Healthcare · Medical - Care Facilities
Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
Enhabit, Inc. currently has a negative P/E ratio, indicating the company is operating at a loss on a trailing-twelve-month basis. On a free-cash-flow basis, the stock trades at 14.5x P/FCF, 51% above the 5-year average of 9.6x.
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Market Cap | $686M | $392M | $516M | $659M | — | — |
| Enterprise Value | $1.2B | $933M | $1.1B | $1.3B | — | — |
| P/E Ratio → | -4.38 | — | — | 10.53 | — | — |
| P/S Ratio | 0.66 | 0.38 | 0.49 | 0.62 | — | — |
| P/B Ratio | 1.23 | 0.71 | 0.74 | 0.85 | — | — |
| P/FCF | 14.47 | 8.27 | 11.50 | 9.03 | — | — |
| P/OCF | 13.40 | 7.66 | 10.67 | 8.23 | — | — |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| EV / Revenue | — | 0.90 | 1.05 | 1.18 | — | — |
| EV / EBITDA | — | — | — | 58.41 | — | — |
| EV / EBIT | — | — | — | — | — | — |
| EV / FCF | — | 19.69 | 24.48 | 17.28 | — | — |
Margins and return-on-capital ratios measuring operating efficiency
Enhabit, Inc. earns an operating margin of -11.1%. Operating margins have compressed from -1.1% to -11.1% over the past 3 years, signaling potential cost pressures or competitive headwinds. A negative ROE of -24.9% indicates the company is currently destroying shareholder equity.
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Gross Margin | 48.7% | 48.7% | 48.8% | 50.9% | 53.6% | 50.1% |
| Operating Margin | -11.1% | -11.1% | -4.5% | -1.1% | 12.9% | 9.5% |
| Net Profit Margin | -15.1% | -15.1% | -7.7% | -3.8% | 10.0% | 7.0% |
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| ROE | -24.9% | -24.9% | -10.9% | -3.6% | 7.7% | 5.4% |
| ROA | -11.7% | -11.7% | -5.4% | -2.5% | 6.7% | 4.6% |
| ROIC | -7.3% | -7.3% | -2.7% | -0.6% | 7.3% | 5.5% |
| ROCE | -9.6% | -9.6% | -3.5% | -0.8% | 9.3% | 6.9% |
Solvency and debt-coverage ratios — lower is generally safer
Net debt stands at $541M ($570M total debt minus $28M cash).
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Debt / Equity | 1.03 | 1.03 | 0.87 | 0.81 | 0.04 | 0.04 |
| Debt / EBITDA | — | — | — | 28.94 | 0.32 | 0.35 |
| Net Debt / Equity | — | 0.98 | 0.83 | 0.78 | 0.03 | 0.01 |
| Net Debt / EBITDA | — | — | — | 27.88 | 0.29 | 0.08 |
| Debt / FCF | — | 11.42 | 12.98 | 8.25 | 0.43 | 0.55 |
| Interest Coverage | -2.68 | -2.68 | -1.11 | -0.76 | 476.33 | 19.75 |
Short-term solvency ratios and asset-utilisation metrics
A current ratio of 1.53x means Enhabit, Inc. can comfortably meet its short-term obligations, though there is limited excess liquidity. The current ratio has declined from 1.59x to 1.53x over the past 3 years.
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Current Ratio | 1.53 | 1.53 | 1.53 | 1.59 | 1.31 | 1.44 |
| Quick Ratio | 1.53 | 1.53 | 1.53 | 1.59 | 1.31 | 1.44 |
| Cash Ratio | 0.23 | 0.23 | 0.20 | 0.17 | 0.04 | 0.30 |
| Asset Turnover | — | 0.84 | 0.73 | 0.70 | 0.64 | 0.67 |
| Inventory Turnover | — | — | — | — | — | — |
| Days Sales Outstanding | — | 52.63 | 57.46 | 54.86 | 54.26 | 46.21 |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Enhabit, Inc. does not currently pay a dividend and has no material buyback yield, reinvesting earnings back into the business.
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Dividend Yield | — | — | — | 99.3% | — | — |
| Payout Ratio | — | — | — | — | 138.7% | 192.7% |
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Earnings Yield | — | — | — | 9.5% | — | — |
| FCF Yield | 6.9% | 12.1% | 8.7% | 11.1% | — | — |
| Buyback Yield | 0.0% | 0.0% | 0.0% | 0.0% | — | — |
| Total Shareholder Yield | 0.0% | 0.0% | 0.0% | 99.3% | — | — |
| Shares Outstanding | — | $50M | $50M | $50M | $4M | $4M |
Compare EHAB with 5 similar companies in its peer group
| Company | Market Cap | P/E | EV/EBITDA | P/FCF | Gross Margin | Op Margin | ROE | ROIC | Debt/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
| EHABYou | $686M | -4.4 | — | 14.5 | 48.7% | -11.1% | -24.9% | -7.3% | — |
| CHE | $6B | 22.3 | 17.3 | 17.8 | — | 13.4% | 25.3% | 23.8% | 0.4 |
| OPCH | $5B | 25.4 | 12.0 | 19.7 | 19.3% | 6.0% | 15.2% | 15.3% | — |
| ADUS | $2B | 19.9 | 13.2 | — | 32.5% | 9.7% | 9.3% | 8.8% | 1.3 |
| AVAH | $2B | -129.8 | 17.3 | 58.2 | 31.4% | 6.9% | — | 8.0% | 8.8 |
| DCGO | $73M | 4.0 | 0.9 | 1.1 | 34.6% | 4.7% | 6.4% | 7.5% | 1.3 |
| Healthcare Median | — | 23.7 | 13.8 | 18.8 | 65.8% | -6.3% | -37.3% | -15.0% | 3.1 |
Peers based on L4 peer group classification. Compare multiple stocks →
Includes 30+ ratios · 5 years · Updated daily
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorSee our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationSee how EHAB stacks up against sector leader Chemed Corporation.
Start ComparisonEnhabit, Inc.'s current P/E ratio is -4.4x. The historical average is 10.5x.
Enhabit, Inc.'s return on equity (ROE) is -24.9%. The historical average is -5.2%.
Based on historical data, Enhabit, Inc. is trading at a P/E of -4.4x. Compare with industry peers and growth rates for a complete picture.
Enhabit, Inc. has 48.7% gross margin and -11.1% operating margin.